Wockhardt gets GMP compliance certificate for Aurangabad plant
New Delhi: Drug firm Wockhardt said the Health Products Regulatory Authority of Ireland has granted certificate of good manufacturing practices (GMP) compliance to its Aurangabad facility after an inspection.
"The Health Products Regulatory Authority of Ireland (HPRA) has granted Certificate of GMP Compliance to our Shendra, Aurangabad facility based on inspection performed from February 27, 2017 to March 3, 2017," Wockhardt said in a BSE filing.
Shares of Wockhardt were trading at Rs 589.05 per scrip on BSE, up 0.43 per cent from previous close.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd